News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
863,429 Results
Type
Article (87557)
Company Profile (827)
Press Release (775025)
Multimedia
Podcasts (179)
Webinars (28)
Section
Business (233109)
Career Advice (4140)
Deals (39815)
Drug Delivery (141)
Drug Development (91290)
Employer Resources (203)
FDA (18302)
Job Trends (17407)
News (397512)
Policy (39932)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (130)
Alliances (56980)
ALS (147)
Alzheimer's disease (1694)
Antibody-drug conjugate (ADC) (269)
Approvals (18344)
Artificial intelligence (519)
Autoimmune disease (107)
Automation (30)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (168)
Biotechnology (485)
Bladder cancer (140)
Brain cancer (53)
Breast cancer (533)
Cancer (4205)
Cardiovascular disease (367)
Career advice (3562)
Career pathing (38)
CAR-T (259)
CDC (57)
Cell therapy (716)
Cervical cancer (33)
Clinical research (75885)
Collaboration (1460)
Company closure (4)
Compensation (970)
Complete response letters (63)
COVID-19 (2966)
CRISPR (85)
C-suite (632)
Cystic fibrosis (142)
Data (5023)
Decentralized trials (2)
Denatured (65)
Depression (115)
Diabetes (471)
Diagnostics (7114)
Digital health (38)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (248)
Drug pricing (196)
Drug shortages (36)
Duchenne muscular dystrophy (210)
Earnings (99464)
Editorial (56)
Employer branding (25)
Employer resources (172)
Events (133627)
Executive appointments (1000)
FDA (20907)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (17)
Funding (1312)
Gene editing (181)
Generative AI (52)
Gene therapy (573)
GLP-1 (1047)
Government (5398)
Grass and pollen (8)
Guidances (374)
Healthcare (20940)
HIV (49)
Huntington's disease (41)
IgA nephropathy (70)
Immunology and inflammation (258)
Immuno-oncology (22)
Indications (60)
Infectious disease (3220)
Inflammatory bowel disease (193)
Inflation Reduction Act (16)
Influenza (104)
Intellectual property (202)
Interviews (816)
IPO (17932)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (82)
Layoffs (643)
Leadership (37)
Legal (10152)
Liver cancer (92)
Longevity (13)
Lung cancer (595)
Lymphoma (289)
Machine learning (33)
Management (66)
Manufacturing (676)
MASH (148)
Medical device (14918)
Medtech (14947)
Mergers & acquisitions (22799)
Metabolic disorders (1212)
Multiple sclerosis (143)
NASH (23)
Neurodegenerative disease (239)
Neuropsychiatric disorders (64)
Neuroscience (2780)
NextGen: Class of 2025 (7707)
Non-profit (5098)
Now hiring (60)
Obesity (585)
Opinion (317)
Ovarian cancer (144)
Pain (173)
Pancreatic cancer (181)
Parkinson's disease (248)
Partnered (32)
Patents (434)
Patient recruitment (344)
Peanut (57)
People (66380)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23405)
Phase II (32929)
Phase III (24832)
Pipeline (3042)
Policy (306)
Postmarket research (3554)
Preclinical (10578)
Press Release (72)
Prostate cancer (207)
Psychedelics (52)
Radiopharmaceuticals (283)
Rare diseases (717)
Real estate (7423)
Recruiting (79)
Regulatory (28169)
Reports (65)
Research institute (2698)
Resumes & cover letters (651)
Rett syndrome (18)
RNA editing (15)
RSV (77)
Schizophrenia (140)
Series A (215)
Series B (160)
Service/supplier (30)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4320)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (112)
Vaccines (1068)
Venture capital (69)
Weight loss (414)
Women's health (63)
Worklife (21)
Date
Today (10)
Last 7 days (1147)
Last 30 days (3328)
Last 365 days (33404)
2025 (28965)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1284)
Alabama (81)
Alaska (7)
Arizona (312)
Arkansas (14)
Asia (51094)
Australia (8982)
California (10042)
Canada (2965)
China (961)
Colorado (420)
Connecticut (445)
Delaware (288)
Europe (117457)
Florida (1471)
Georgia (327)
Hawaii (3)
Idaho (67)
Illinois (833)
India (56)
Indiana (493)
Iowa (20)
Japan (339)
Kansas (127)
Kentucky (39)
Louisiana (25)
Maine (80)
Maryland (1335)
Massachusetts (7498)
Michigan (321)
Minnesota (594)
Mississippi (4)
Missouri (124)
Montana (33)
Nebraska (26)
Nevada (110)
New Hampshire (80)
New Jersey (2772)
New Mexico (32)
New York (2692)
North Carolina (1459)
North Dakota (10)
Northern California (4640)
Ohio (310)
Oklahoma (22)
Oregon (51)
Pennsylvania (2069)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (52)
South Dakota (1)
Southern California (3833)
Tennessee (153)
Texas (1566)
United States (36796)
Utah (301)
Virginia (257)
Washington D.C. (84)
Washington State (856)
West Virginia (4)
Wisconsin (104)
Wyoming (2)
There are 863,429 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Virion Therapeutics Reports Progress Towards HBV Functional Cure with Sustained and Continued HBsAg Declines up to One Year After a Single VRON-0200 Dose From its Phase 1b Study at AASLD’s The Liver Meeting® 2025
November 10, 2025
·
5 min read
Press Releases
Innovent and SanegeneBio Announce Phase 1 Clinical Data for IBI3016 Presented at American Heart Association (AHA) 2025 Annual Meeting
November 10, 2025
·
10 min read
Press Releases
Vir Biotechnology Announces AASLD The Liver Meeting® Presentation & New England Journal of Medicine Publication of Phase 2 Data Demonstrating Tobevibart & Elebsiran Combination Deliver High Rates of Undetectable HDV RNA with Favorable Safety Profile
November 10, 2025
·
9 min read
Press Releases
Kelun-Biotech Presented TROP2 ADC Sacituzumab Tirumotecan Results From Multiple Clinical Studies at the 2025 CCHIO Congress
November 10, 2025
·
8 min read
Press Releases
Rona Therapeutics Presents Phase 1 Data for RN0361, a Long-Acting APOC3-Targeting siRNA, at the American Heart Association 2025 Scientific Sessions
November 10, 2025
·
2 min read
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s fenebrutinib shows unprecedented positive Phase III results as the potential first and only BTK inhibitor in both relapsing and primary progressive multiple sclerosis
November 10, 2025
·
9 min read
Press Releases
BioVersys BV100 Phase 2b to be Conducted Via Wellcome Funded Trial Network
November 10, 2025
·
11 min read
Press Releases
Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL
November 10, 2025
·
7 min read
Press Releases
Genentech’s Fenebrutinib Shows Unprecedented Positive Phase III Results as the Potential First and Only BTK Inhibitor in Both Relapsing and Primary Progressive Multiple Sclerosis
November 10, 2025
·
15 min read
Drug Development
From Weight Loss to Hair Loss: The Search for the Next Blockbuster
A new generation of companies is eyeing the existing, sizeable hair loss market, hoping that better formulations and new scientific targets will finally produce treatments that are safer and more effective, as well as commercially successful.
November 10, 2025
·
6 min read
·
Ben Hargreaves
1 of 86,343
Next
